The most recent batch of warning letters from the U.S. Food and Drug Administration (FDA) were sent to a dairy in Ohio, a juice manufacturer, an acidified foods facility and a seafood processor. Big Prairie, OH, dairy Hyland Acres Jerseys sold a bob veal calf for slaughter in June that FDA considered adulterated because there were residues of neomycin found in the animal’s kidney tissues at 20.99 parts per million (ppm). “Our investigation also found that you hold animals under conditions that are so inadequate that medicated animals bearing potentially harmful drug residues are likely to enter the food supply,” read FDA’s warning letter. The agency also found that the company did not use NeoMed 325 Soluble Powder (Neomycin Sulfat) as directed by its approved labeling and that the extra label use was not under the supervision of a licensed veterinarian. American Spice Trading Company’s Miami facility, which manufactures acidified foods and juice products, was cited for “serious violations” of the juice Hazard Analysis and Critical Control Point (HACCP) regulations and the Current Good Manufacturing Practice (CGMP) regulations for foods. According to FDA’s warning letter, the company’s plan did not include control measures for ensuring that a 5-log reduction of pertinent microorganisms is “applied and consistent.” It also included a corrective action of adding citric acid, which is not considered appropriate for “lemon juice from concentrate” since added citric acid is not an ingredient permitted by the standard of identity for lemon juice from concentrate. The company’s Pampas brand Lemon Juice product did not list the pertinent microbiological hazards that are specifically related to juice products, such as Salmonella, Escherichia coli O157:H7, and Listeria Monocytogenes, FDA stated. After identifying these hazards, the company also has to include control measures for monitoring them. American Spice also failed to validate and maintain documentation of data validation for the critical factors with its “Liquid Blends – Acidic Juices” HACCP plan and to monitor the safety of water, prevent cross-contamination from insanitary objects to food, and exclude pests with sufficient frequency, according to the warning letter. In June, FDA inspected the facility of a Korean manufacturer of acidified food products exported into the U.S. The agency noted that Kilim Nong San of Pucheon-si, Kyungki-do, Korea had “a serious deviation from the Emergency Permit Control regulation.” The company responded in July, but FDA decided that the firm has not made adequate corrections. Specifially, Kilim Nong San noted the changes it had made, but did not include supporting documentation, such as processing records showing adherence to its scheduled processes. The company also included microbiological tests for E. coli in support of cook time and temperature, but FDA responded in their letter sent at the end of September that “such test results do not substitute for the establishment of a valid process established by a processing authority.” Yamaharu Company’s seafood processing facility in Tokyo was cited for violations of the seafood HACCP regulations. FDA cited the company for failure to list critical limits to control scombrotoxin (histamine) formation and found monitoring procedures inadequate to ensure that Yamaharu meets critical limits. In each letter, FDA requested that the companies provide written responses detailing steps taken to bring the facilities into compliance with food safety laws and regulations, to correct violations cited in the letters, and to prevent their recurrence. Recipients of these warning letters have 15 working days from receipt to outline specific steps they have taken to come into compliance with the law.